When Inheriting a Patient Panel Means Inheriting Unsafe Prescribing
Last updated 3/24/26
🚨 Part 1 of 4: The Xanax Trap
A version of this question comes up regularly in NP communities, almost always from someone who is new to her workplace:
“I inherited a panel and I’m realizing the previous provider was prescribing chronic benzodiazepines and managing psychiatric conditions that are really outside of primary care. I want to practice safely but I’m not sure how to transition these patients without everything blowing up.”
Here is the honest answer: things are going to blow up. Patients will be upset. People around you will pressure you to go along. Some of them will do it politely and some of them will not. If you want to practice safely, you do not have a choice about any of that.
I know this because I have been in this exact position. Here is what happened, and here is what to do.
What should you expect when you refuse to continue unsafe prescribing?
Answer capsule: Patients will be upset. Colleagues, pharmacy, and social work may pressure you. Leadership may pressure you while privately agreeing you are right. Expect all of it.
When I inherited the panel of a retired physician who had not updated his prescribing habits in two decades, I was looking at chronic opioids for non-cancer pain and long-term benzodiazepines for anxiety. Both were well outside the current standard of care.
The pushback came from every direction.
Patients accused me of abandonment. Some threatened to file complaints or sue. Colleagues told me to just go with the flow. Some of them had their own reasons for wanting me to stay quiet: if I was practicing differently, it raised questions about how they were practicing. Others ended up with my former patients transferring to their schedules and discovered they would have to fulfill the same demands I had refused to fulfill.
Pharmacy sent me messages about patients causing a commotion because I had changed their medications. The messages had a particular tone, as if the appropriate clinical response to a patient’s frustration was to reverse the clinical decision. I did not reverse the decisions.
Social workers argued that I should prescribe what the patients had been taking. This happened more than once. My answer was consistent: if they felt that strongly about what those patients should be prescribed, they were welcome to prescribe it themselves. They could not, because they are not prescribers. But the fact that they were making that argument at all tells you something about the culture I was working in.
Leadership told me to my face that the previous provider’s prescribing was unsafe. They also pressured me not to be disruptive about it. Those two positions cannot coexist, and when I pointed that out, the pressure continued anyway.
You will still be standing on solid ground when all of that happens. Prescribing is a privilege that can be revoked. Malpractice attorneys are not interested in your good intentions.
Is an NP obligated to continue a previous provider's prescribing plan?
Answer capsule: No. You are responsible for what you prescribe. A predecessor’s plan does not transfer liability away from your license.
Your scope of practice is not negotiable based on what the person before you was doing. Managing chronic opioid pain syndromes, treatment-resistant anxiety, and complex psychiatric polypharmacy fall outside the typical training and licensure of an FNP, regardless of what the last provider signed.
Not continuing an out-of-scope prescription is no different from not performing a surgical procedure or not prescribing a chemotherapy regimen when your education and training justify you doing so. You are not withholding care. You are practicing within the scope of the license and training you actually have.
When you refuse to prescribe outside your scope, you are affirming the patient’s safety. That’s how you explain your need to stand your ground to patients, colleagues, and bosses who just wish you would go with the flow.
What are the two moves to make when you inherit an unsafe prescribing panel?
Answer capsule: Refill and refer, or redirect to leadership. One routes the patient to appropriate specialty care. The other puts the liability decision back where it belongs.
Move 1: Refill and Refer
For patients on chronic benzodiazepines, opioids, stimulants, or hypnotics, give a single short-term refill covering the time it takes to get a specialist appointment and send an immediate referral to the appropriate specialty: pain management, psychiatry, or behavioral health.
Frame the referral to the patient as a team-based approach. You want them to have access to a clinician whose license and training is built for this kind of management. That is accurate, and most patients respond better to that framing than to a flat refusal.
Move 2: Redirect to Leadership
For the most clinically inappropriate cases, transfer the care directly to your medical director.
Your medical director’s license works the same way yours does. If leadership did not have a problem with the previous provider’s prescribing habits, they cannot reasonably have a problem managing those patients themselves. That is not a confrontational framing. It is a factual one.
Here is what actually happened when I did this.
My medical director took the patients. About six weeks later, he told me he felt “icky” refilling those prescriptions and that he was overwhelmed. He tried to distribute the patients to other newer providers on staff. Word had gotten around about my refusal to continue clinically unjustifiable prescribing, and those providers refused too. One of them told me he had been trying to call attention to this problem for months and that nobody had listened to him.
Eventually there were enough of us refusing to do things the old way that the organization held a meeting. The directors of pharmacy, behavioral health, and primary care presented new policies and practice guidelines that were, in fact, evidence-based.
By then, my medical director was riding out his resignation notice. I had also given notice. I was tired of fighting, and relief had come too late. The institution had ignored the provider who raised the alarm first, bullied others into maintaining the status quo, and could not outright terminate me because I was on solid clinical ground. But it could not sustain the position it had forced the rest of us into either.
That is the realistic arc. You may be right and it may still cost you. The institutional change, when it comes, tends to come after enough people refuse together, not because one person held the line alone.
If leadership asks you in writing to continue prescribing outside your scope or the current standard of care, that written request is documentation. Keep it.
How should you prioritize a high-risk inherited panel?
Answer capsule: Review the chart before the first visit. Stratify by risk level. You cannot address every patient at once.
Before you see any of these patients, review the charts and flag:
Length of time on benzodiazepines, opioids, stimulants, or hypnotics and current dose
Any history of substance use disorder, falls, overdose, or ED visits
Co-prescribing of other sedating agents: opioids, gabapentin, trazodone
Prior psychiatric referrals or documented failed taper attempts
That stratification tells you who needs an immediate, firm boundary at the first visit and who can move through a slower transition. Know who your highest-risk patients are before they walk in the door.
How do you handle the first visit with a patient who expects a refill you won't write?
Answer capsule: Establish yourself as an ally, not an adversary. Explain the clinical reason. Collaborate on a plan. Document the entire conversation.
Your goal in the first visit is not to deliver a refusal. It is to establish a relationship and a plan.
Acknowledge that the patient has been managed this way for a long time. Tell them that abrupt discontinuation is dangerous and that you will not do that to them. Make clear that your job is to follow evidence-based guidelines that keep them safe, and that sometimes that means changing a management plan, not abandoning the patient.
For chronic benzodiazepine, opioid, stimulant, or hypnotic users, a gradual taper at 5 to 10 percent every two to four weeks reduces panic, withdrawal symptoms, and the adversarial dynamic that makes these visits harder. Flexibility on the pace communicates that you are not trying to punish them.
Document everything: the patient’s response, your clinical reasoning, the taper plan, the referral, and the fact that behavioral health was offered even if refused. Boundaries are a clinical intervention. They belong in the chart.
What can you do with this information today?
Answer capsule: Before your first visit with an inherited high-risk patient, review the chart for the four risk factors above and decide which of the two moves applies.
You do not need a policy, a meeting, or leadership’s blessing to do that preparation. The chart is available now. The risk stratification takes a few minutes per patient. Knowing which patients need an immediate boundary and which can move through a slower transition is the first decision, and it is one you can make before you are standing in the room with someone who is angry.
Get the Free NP Workflow & Survival Guide
Navigating a high-risk panel without a workflow structure is how one problem becomes ten. The NP Workflow and Survival Guide addresses the administrative and operational realities that make boundary-setting harder than it should be.
Get the Free NP Workflow & Survival Guide
Read This Whole Series
Part 2: When Safe Practice Makes You the "Difficult" Provider
Part 3: Unsafe Prescribing Is a System Problem, Not Just a Provider Problem
Part 4: How to Leave a Toxic Practice (or Survive It) with Your Professional Identity Intact
The Refill Request Message Master Kit is a targeted resource for primary care providers designed to streamline medication management. It provides pre-written, customizable templates and a comprehensive workflow guide to efficiently respond to, approve, or reject refill requests. Quickly communicate critical decisions, ensure patient safety with re-evaluation protocols, and reduce the time spent managing this high-volume, administrative task to reclaim your evenings and weekends.
